Palliative and adjuvant regional chemotherapy in pancreatic cancer

European Journal of Surgical Oncology

Volumn 23, Issue 5, 1997, Pages 409-414

  Link, Karl H ^a   Gansauge, Frank ^a   Görich, Johannes ^a   Leder, Gerd H ^a   Rilinger, Norbert ^a   Beger, Hans G ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Cancer; Chemotherapy; Coeliac artery infusion; Pancreas; Therapy

Indexed keywords

ADJUVANT; CISPLATIN; FLUOROURACIL; FOLINATE CALCIUM; FOLINIC ACID; MITOXANTRONE;

ADULT; AGED; ARTICLE; BONE MARROW SUPPRESSION; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER SURGERY; CELIAC ARTERY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG INFUSION; DUODENUM ULCER; FEMALE; GASTRITIS; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; LIVER DISEASE; MALE; NAUSEA; PAIN; PANCREAS CANCER; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL ANALYSIS; STOMACH ULCER; SURVIVAL TIME; VOMITING; WORLD HEALTH ORGANIZATION;

EID: 0030778381     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0748-7983(97)93720-3     Document Type: Article

References (37)

1. Gudjonsson B. Cancer of the pancreas: 50 years of surgery. Cancer 1987; 60: 2284-303.
2. Bakkevold KE, Kambestad B. Long-term survival following radical and palliative treatment of patients with carcinoma of the pancreas and papilla of Vater - The prognostic factors influencing the long-term results. Eur J Surg Oncol 1993; 19: 147-61.
3. Gall FP, Zirngibl H. In: Gall FP, Hermanek P, Tonak J (eds). Chirurgische Onkologie - Histologie- und stadiengerechte Therapie maligner Tumoren. Berlin-Heidelberg-New York: Springer-Verlag, 1986: 416-60.
4. Warshaw AL, Fernández-Del Castillo C. Pancreatic carcinoma. N Engl J Med 1992; 326: 455-65.
5. Gastrointestinal Tumor Study Group. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Cancer 1987; 59: 2006-10.
6. Kalser MH, Ellenberg SS. Pancreatic cancer. Adjuvant combined radiation & chemotherapy following curative resection. Arch Surg 1985; 120: 899-903.
7. Douglass HO, Jr. Adjuvant therapy for pancreatic cancer. World J Surg 1995; 19: 270-4.
8. Bakkevold KE, Arnesjo B, Dahl O, Kambestad B. Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of Vater: results of a controlled, prospective randomised multicentre study. Eur J Cancer 1993; 29A: 698-703.
9. Douglass HO. The need for further adjuvant trials in gastrointestinal cancer. Onkologie 1991; 14: 114-22.
10. Moertel CG, Gunderson LL, Mailliard JA, et al. Early evaluation of combined Fluorouracil and Leucovorin as a radiation enhancer for locally unresectable, residual, or recurrent gastrointestinal carcinoma. J Clin Oncol 1994; 12: 21-7.
11. Arbuck SG. Overview of chemotherapy for pancreatic cancer. Int J Pancreatol 1990; 7: 209-22.
12. Moore M, Andersen J, Burns H, et al. A randomized trial of gemcitabine (GEM) versus 5-FU as first line therapy in advanced pancreatic cancer. Proceedings of ASCO 1995; 14: 199.
13. Palmer KR, Kerr M, Knowles G, Cull A, Carter DC, Leonard RCF. Chemotherapy prolongs survival in inoperable pancreatic carcinoma. Br J Cancer 1994; 81: 882-5.
14. Taylor I. Should further studies of chemotherapy by carried out in pancreatic cancer? Eur J Cancer 1993; 29A: 1076-8.
15. Aigner KR, Gailhofer S. Celiac axis infusion (MMC, CDDP, 5-FU) and aortic stop-flow infusion vs abdominal -hypoxic perfusion (MMC) in UICC stage III/IV pancreatic cancer - 48 patients. Reg Cancer Treat 1993; (Suppl. 1): 2.
16. Ohigashi H, Ishikawa O, Nakamori S, Sasaki Y, et al. Evaluation of intra-arterial infusion chemotherapy and radical pancreatectomy in patients with locally advanced pancreatic cancer. Gan To Kagaku Ryoho 1993; 20: 1672-5.
17. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981; 47: 207-14.
18. Wils JA. Chemotherapy in pancreatic cancer: a rational pursuit? Anticancer Drugs 1991; 2: 3-10.
19. Warshaw AL, Swanson RS. Pancreatic cancer in 1988. Possibilities and probabilities. Ann Surg 1988; 208: 541-53.
20. Beger HG, Büchler MW, Friess H. Chirurgische Ergebnisse und Indikation zu adjuvanten Maßnahmen beim Pankreascarcinom. Chirurg 1994; 65: 246-52.
21. Weiss L, Harlos JP, Hartveit F, et al. Metastatic pattern from cancers of the pancreas: an analysis of 558 autopsies. Reg Cancer Treat 1992; 4: 265-71.
22. Andren-Sandberg A, Westerdahl J, Ihse I. Recurrence after pancreatectomy for pancreatic cancer. Digestion 1992; 52: 67.
23. Foo ML, Gunderson LL, Nagorney DM, et al. Patterns of failure in grossly resected pancreatic ductal adenocarcinoma treated with adjuvant irradiation +/- 5 fluorouracil. Int J Radiat Oncol Biol Phys 1993; 26: 483-9.
24. Bruckner HW, Kalnicki S, Dalton J, et al. Survival after combined modality therapy for pancreatic cancer. J Clin Gastroenterol 1993; 16: 199-203.
25. Baumel H, Huguier M, Manderscheid JC, Fabre JM, Houry S, Fagot H. Results of resection for cancer of the exocrine pancreas: a study from the French Association of Surgery. Br J Surg 1994; 81: 102-7.
26. Link KH, Kindler D, Hummel M, Büchler M. Dose response treatment studies with two pancreatic carcinoma cell lines in vitro. Digestion 1992; 52: 102.
27. Link KH, Staib L, Beger HO. Influence of exposure concentration and exposure time cxt on toxicity of cytostatic drugs to HT29 human colorectal carcinoma cells. Reg Cancer Treat 1989; 2: 189-97.
28. Link KH, Hepp G, Butzer U, et al. Rationales for intraperitoneal chemotherapy: chemosensitivity testing and pharmacokinetic considerations - clinical experience with intraperitoneal chemotherapy. Acta Chir Austriaca 1995; 27: 95-100.
29. Patt YZ, Mavligit GM. Arterial chemotherapy in the management of colorectal cancer. An overview. Semin Oncol 1991; 18: 478-90.
30. Rougier P, Laplanche A, Huguier M, et al. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial. J Clin Oncol 1992; 10: 1112-8.
31. Donatini B, Rougier P. Anatomical basis for pancreatic locoregional chemotherapy. Reg Cancer Treat 1992; 4: 272-6.
32. Aigner KR, Müller H, Bassermann R. Intra-arterial chemotherapy with MMC, CDDP and 5-FU for nonresectable pancreatic cancer - a phase II study. Reg Cancer Treat 1990; 3: 1-6.
33. Link KH, Gansauge F, Pillasch J, Rilinger N, Büchler M, Beger HG. Regional treatment of advanced nonresectable and of resected pancreatic cancer via celiac axis infusion. First results of a single institution study. Dig Surg 1994; 11: 414-9.
34. Arbuck SO. Chemotherapy for pancreatic cancer. Clin Gastroenterol 1990; 4: 953-68.
35. Bruckner HW, Kalnicki S, Dalton J, et al. Combined modality therapy increasing local control of pancreatic cancer. Cancer Invest 1993; 11: 241-6.
36. Ohigashi H, Ishikawa O, Masutami S, et al. Arterial infusion therapy for liver and loco-regional treatment with arterial infusion and irradiation for pancreas tumor in non-resectable pancreas cancer with liver metastases. Jpn J Cancer Chemother 1991; 8: 1776-9.
37. Ishikawa O, Ohigashi H, Sasaki Y, et al. Liver perfusion chemotherapy via both the hepatic artery and portal vein to prevent hepatic metastasis after extended pancreatectomy for adenocarcinoma of the pancreas. Am J Surg 1994; 168: 361-4.